News
Addex Therapeutics leads CHF 2 million investment in Stalicla to advance precision medicine in neuropsychiatric disorders: Geneva, Switzerland Tuesday, July 1, 2025, 11:00 Hrs [IS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback